With 0.12 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.15 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.28 whereas the lowest price it dropped to was $1.97. The 52-week range on ENTO shows that it touched its highest point at $2.78 and its lowest point at $0.84 during that stretch. It currently has a 1-year price target of $108.00. Beta for the stock currently stands at 0.93.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ENTO was up-trending over the past week, with a rise of 11.52%, but this was up by 72.35% over a month. Three-month performance surged to 74.93% while six-month performance rose 53.29%. The stock gained 21.92% in the past year, while it has gained 74.33% so far this year.
Float and Shares Shorts:
At present, 1.59 million ENTO shares are outstanding with a float of 1.48 million shares on hand for trading. On 2025-08-15, short shares totaled 84404.0, which was 531.0 higher than short shares on 1752537600. In addition to Mr. Richard Joel Paolone as the firm’s Interim CEO & Chairman, Ms. Anna Skowron serves as its Interim Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, ENTO reported revenue of $0.0 and operating income of -$638864.0. The EBITDA in the recently reported quarter was -$638864.0 and diluted EPS was -$0.63.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.39 being high and -$3.39 being low. For ENTO, this leads to a yearly average estimate of -$3.39. The surprise factor in the prior quarter was -$4.65.
